Expanded 2-Year Follow-up of Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema von Elman, Michael J., MD, Bressler, Neil M., MD, Qin, Haijing, MS, Beck, Roy W., MD, PhD, Ferris, Frederick L., MD, Friedman, Scott M., MD, Glassman, Adam R., MS, Scott, Ingrid U., MD, MPH, Stockdale, Cynthia R., MSPH, Sun, Jennifer K., MD, MPH

Volltext

Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema von Elman, Michael J., MD, Aiello, Lloyd Paul, MD, PhD, Beck, Roy W., MD, PhD, Bressler, Neil M., MD, Bressler, Susan B., MD, Edwards, Allison R., MS, Ferris, Frederick L., MD, Friedman, Scott M., MD, Glassman, Adam R., MS, Miller, Kellee M., MPH, Scott, Ingrid U., MD, MPH, Stockdale, Cynthia R., MSPH, Sun, Jennifer K., MD, MPH

Volltext

Intravitreal Ranibizumab for Diabetic Macular Edema with Prompt versus Deferred Laser Treatment: 5-Year Randomized Trial Results von Elman, Michael J., MD, Ayala, Allison, MS, Bressler, Neil M., MD, Browning, David, MD, Flaxel, Christina J., MD, Glassman, Adam R., MS, Jampol, Lee M., MD, Stone, Thomas W., MD

Volltext

Five-Year Outcomes after Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T Extension Study) von Glassman, Adam R., Wells, John A., Josic, Kristin, Maguire, Maureen G., Antoszyk, Andrew N., Baker, Carl, Beaulieu, Wesley T., Elman, Michael J., Jampol, Lee M., Sun, Jennifer K.

Volltext

Randomized Trial of a Home Monitoring System for Early Detection of Choroidal Neovascularization Home Monitoring of the Eye (HOME) Study von Chew, Emily Y., MD, Clemons, Traci E., PhD, Bressler, Susan B., MD, Elman, Michael J., MD, Danis, Ronald P., MD, Domalpally, Amitha, MD, Heier, Jeffrey S., MD, Kim, Judy E., MD, Garfinkel, Richard, MD

Volltext

Advances in the treatment of diabetic retinopathy von Singh, Rishi P., Elman, Michael J., Singh, Simran K., Fung, Anne E., Stoilov, Ivaylo

Volltext

Predictors of Diabetic Macular Edema Treatment Frequency with Ranibizumab During the Open-Label Extension of the RIDE and RISE Trials von Wykoff, Charles C., MD, PhD, Elman, Michael J., MD, Regillo, Carl D., MD, Ding, Beiying, PhD, Lu, Na, PhD, Stoilov, Ivaylo, MD

Volltext

All Patients Treated for Proliferative Diabetic Retinopathy Need to Be Monitored Carefully over Time for Further Treatment von Elman, Michael J.

Volltext

Evaluation of a self-imaging SD-OCT system designed for remote home monitoring von Kim, Judy E, Tomkins-Netzer, Oren, Elman, Michael J, Lally, David R, Goldstein, Michaella, Goldenberg, Dafna, Shulman, Shiri, Benyamini, Gidi, Loewenstein, Anat

Volltext

Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema von Wells, John A, Glassman, Adam R, Ayala, Allison R, Jampol, Lee M, Aiello, Lloyd Paul, Antoszyk, Andrew N, Arnold-Bush, Bambi, Baker, Carl W, Bressler, Neil M, Browning, David J, Elman, Michael J, Ferris, Frederick L, Friedman, Scott M, Melia, Michele, Pieramici, Dante J, Sun, Jennifer K, Beck, Roy W

Volltext

Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial von Gross, Jeffrey G, Glassman, Adam R, Jampol, Lee M, Inusah, Seidu, Aiello, Lloyd Paul, Antoszyk, Andrew N, Baker, Carl W, Berger, Brian B, Bressler, Neil M, Browning, David, Elman, Michael J, Ferris, Frederick L, Friedman, Scott M, Marcus, Dennis M, Melia, Michele, Stockdale, Cynthia R, Sun, Jennifer K, Beck, Roy W

Volltext

Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial von Gross, Jeffrey G, Glassman, Adam R, Liu, Danni, Sun, Jennifer K, Antoszyk, Andrew N, Baker, Carl W, Bressler, Neil M, Elman, Michael J, Ferris, Frederick L, Gardner, Thomas W, Jampol, Lee M, Martin, Daniel F, Melia, Michele, Stockdale, Cynthia R, Beck, Roy W

Volltext

Retinal Specialist versus Artificial Intelligence Detection of Retinal Fluid from OCT: Age-Related Eye Disease Study 2: 10-Year Follow-On Study von Keenan, Tiarnan D L, Clemons, Traci E, Domalpally, Amitha, Elman, Michael J, Havilio, Moshe, Agrón, Elvira, Benyamini, Gidi, Chew, Emily Y

Volltext

Intravitreal Ranibizumab for Diabetic Macular Edema with Prompt versus Deferred Laser Treatment: Three-Year Randomized Trial Results von ELMAN, Michael J, HAIJING QIN, AIELLO, Lloyd Paul, BECK, Roy W, BRESSLER, Neil M, FERRIS, Frederick L, GLASSMAN, Adam R, MATURI, Raj K, MELIA, Michele

Volltext

Secondary Analyses of the Effects of Lutein/Zeaxanthin on Age-Related Macular Degeneration Progression: AREDS2 Report No. 3 von Chew, Emily Y, Clemons, Traci E, SanGiovanni, John Paul, Danis, Ronald P, Ferris, Frederick L, Elman, Michael J, Antoszyk, Andrew N, Ruby, Alan J, Orth, David, Bressler, Susan B, Fish, Gary E, Hubbard, George Baker, Klein, Michael L, Chandra, Suresh R, Blodi, Barbara A, Domalpally, Amitha, Friberg, Thomas, Wong, Wai T, Rosenfeld, Philip J, Agrón, Elvira, Toth, Cynthia A, Bernstein, Paul S, Sperduto, Robert D

Volltext

Dexamethasone implant anterior chamber migration: risk factors, complications, and management strategies von Khurana, Rahul N, Appa, Suri N, McCannel, Colin A, Elman, Michael J, Wittenberg, Susan E, Parks, David J, Ahmad, Saad, Yeh, Steven

Volltext

Visual Acuity, Vitreous Hemorrhage, and Other Ocular Outcomes After Vitrectomy vs Aflibercept for Vitreous Hemorrhage Due to Diabetic Retinopathy: A Secondary Analysis of a Randomi... von Glassman, Adam R, Beaulieu, Wesley T, Maguire, Maureen G, Antoszyk, Andrew N, Chow, Clement C, Elman, Michael J, Jampol, Lee M, Salehi-Had, Hani, Sun, Jennifer K

Volltext

A Phase II Randomized Clinical Trial of Intravitreal Bevacizumab for Diabetic Macular Edema von Scott, Ingrid U, Edwards, Allison R, Beck, Roy W, Bressler, Neil M, Chan, Clement K, Elman, Michael J, Friedman, Scott M, Greven, Craig Michael, Maturi, Raj K, Pieramici, Dante J, Shami, Michel, Singerman, Lawrence J, Stockdale, Cynthia R

Volltext

Lutein/Zeaxanthin for the Treatment of Age-Related Cataract: AREDS2 Randomized Trial Report No. 4 von Chew, Emily Y, SanGiovanni, John Paul, Ferris, Frederick L, Wong, Wai T, Agron, Elvira, Clemons, Traci E, Sperduto, Robert, Danis, Ronald, Chandra, Suresh R, Blodi, Barbara A, Domalpally, Amitha, Elman, Michael J, Antoszyk, Andrew N, Ruby, Alan J, Orth, David, Bressler, Susan B, Fish, Gary E, Hubbard, George B, Klein, Michael L, Friberg, Thomas R, Rosenfeld, Philip J, Toth, Cynthia A, Bernstein, Paul

Volltext

Association of Baseline Visual Acuity and Retinal Thickness With 1-Year Efficacy of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema von Wells, John A, Glassman, Adam R, Jampol, Lee M, Aiello, Lloyd Paul, Antoszyk, Andrew N, Baker, Carl W, Bressler, Neil M, Browning, David J, Connor, Crystal G, Elman, Michael J, Ferris, Frederick L, Friedman, Scott M, Melia, Michele, Pieramici, Dante J, Sun, Jennifer K, Beck, Roy W

Volltext